| # | Title | Journal | Year | Citations |
|---|
| 1 | Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria | Lancet Neurology, The | 2018 | 4,605 |
| 2 | Neuroinflammation in Alzheimer's disease | Lancet Neurology, The | 2015 | 4,129 |
| 3 | Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration | Lancet Neurology, The | 2013 | 3,919 |
| 4 | Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade | Lancet Neurology, The | 2010 | 3,792 |
| 5 | Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria | Lancet Neurology, The | 2007 | 3,755 |
| 6 | Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers | Lancet Neurology, The | 2013 | 3,378 |
| 7 | Epidemiology of Parkinson's disease | Lancet Neurology, The | 2006 | 3,329 |
| 8 | A clinical approach to diagnosis of autoimmune encephalitis | Lancet Neurology, The | 2016 | 2,782 |
| 9 | Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis | Lancet Neurology, The | 2015 | 2,776 |
| 10 | Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies | Lancet Neurology, The | 2008 | 2,696 |
| 11 | Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria | Lancet Neurology, The | 2014 | 2,657 |
| 12 | Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | Lancet Neurology, The | 2019 | 2,625 |
| 13 | Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges | Lancet Neurology, The | 2010 | 2,586 |
| 14 | Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study | Lancet Neurology, The | 2013 | 2,382 |
| 15 | Cognitive reserve in ageing and Alzheimer's disease | Lancet Neurology, The | 2012 | 2,347 |
| 16 | Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 | Lancet Neurology, The | 2021 | 2,308 |
| 17 | Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review | Lancet Neurology, The | 2009 | 2,255 |
| 18 | Non-motor symptoms of Parkinson's disease: diagnosis and management | Lancet Neurology, The | 2006 | 2,202 |
| 19 | The projected effect of risk factor reduction on Alzheimer's disease prevalence | Lancet Neurology, The | 2011 | 2,164 |
| 20 | Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis | Lancet Neurology, The | 2011 | 2,039 |
| 21 | Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis | Lancet Neurology, The | 2010 | 2,035 |
| 22 | Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances | Lancet Neurology, The | 2009 | 2,006 |
| 23 | Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | Lancet Neurology, The | 2019 | 2,005 |
| 24 | Potential for primary prevention of Alzheimer's disease: an analysis of population-based data | Lancet Neurology, The | 2014 | 1,903 |
| 25 | The spectrum of neuromyelitis optica | Lancet Neurology, The | 2007 | 1,897 |
| 26 | Risk of dementia in diabetes mellitus: a systematic review | Lancet Neurology, The | 2006 | 1,791 |
| 27 | Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study | Lancet Neurology, The | 2013 | 1,738 |
| 28 | Moderate and severe traumatic brain injury in adults | Lancet Neurology, The | 2008 | 1,715 |
| 29 | Cognitive impairment in multiple sclerosis | Lancet Neurology, The | 2008 | 1,709 |
| 30 | Motor recovery after stroke: a systematic review | Lancet Neurology, The | 2009 | 1,706 |
| 31 | Neuroinflammation in Parkinson's disease: a target for neuroprotection? | Lancet Neurology, The | 2009 | 1,648 |
| 32 | An active and socially integrated lifestyle in late life might protect against dementia | Lancet Neurology, The | 2004 | 1,647 |
| 33 | Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century | Lancet Neurology, The | 2003 | 1,612 |
| 34 | Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management | Lancet Neurology, The | 2010 | 1,605 |
| 35 | Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials | Lancet Neurology, The | 2007 | 1,580 |
| 36 | Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | Lancet Neurology, The | 2018 | 1,573 |
| 37 | Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research | Lancet Neurology, The | 2017 | 1,571 |
| 38 | Neurological associations of COVID-19 | Lancet Neurology, The | 2020 | 1,550 |
| 39 | Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | Lancet Neurology, The | 2017 | 1,521 |
| 40 | Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | Lancet Neurology, The | 2019 | 1,512 |
| 41 | Cerebral microbleeds: a guide to detection and interpretation | Lancet Neurology, The | 2009 | 1,503 |
| 42 | Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study | Lancet Neurology, The | 2006 | 1,494 |
| 43 | Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies | Lancet Neurology, The | 2019 | 1,414 |
| 44 | CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis | Lancet Neurology, The | 2016 | 1,413 |
| 45 | Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis | Lancet Neurology, The | 2011 | 1,395 |
| 46 | Huntington's disease: from molecular pathogenesis to clinical treatment | Lancet Neurology, The | 2011 | 1,393 |
| 47 | Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis | Lancet Neurology, The | 2009 | 1,380 |
| 48 | Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment | Lancet Neurology, The | 2009 | 1,367 |
| 49 | Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study | Lancet Neurology, The | 2008 | 1,340 |
| 50 | Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment | Lancet Neurology, The | 2010 | 1,303 |
